Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 1302-5 (MIR1302-5) is a human microRNA gene located on chromosome 20 that produces a mature microRNA (miRNA) through canonical miRNA biogenesis, including processing by Drosha and Dicer enzymes[2][1]. The mature miR-1302-5 molecule functions within the RISC complex, regulating the translation and stability of multiple target mRNAs by imperfect base pairing[2]. MIR1302-5 belongs to the larger miR-1302 family, which originated from MER53 transposable elements and exhibits considerable evolutionary diversity among placental mammals[1][3]. Genomic studies suggest its target genes are over-represented in pathways related to cellular transport, localization, development, binding, and transcription regulation, although its precise biological or disease role in humans remains undetermined[1][2]. There are no current drugs or therapies directly targeting MIR1302-5, and it is not an established biomarker or therapeutic target as of this writing[2][1][3].\n\nIf more specific functional or disease data is needed, additional experimental and clinical studies are required, as the functional characterization of MIR1302-5 is still largely unexplored[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 1302-5 (MIR1302-5).